Financial Calendar
POXEL (Euronext - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and NASH, announces its schedule for the publication of financial information for 2018.
| Event | Date* |
|---|---|
| 2017 Q4 Financial Update | January 22, 2018 |
| 2017 Full Year Financial Statement | March 22, 2018 |
| 2018 Q1 Financial Update | April 23, 2018 |
| 2018 Q2 Financial Update | July 10, 2018 |
| 2018 First Half Financial Statement | September 19, 2018 |
| 2018 Q3 Financial Update | October 16, 2018 |
| 2018 Q4 Financial Update | February 12, 2019 |
*Subject to modification.